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A B S T R A C T
BACKGROUND AND PURPOSE: Early white matter (WM) changes and cortical atrophy in Huntington’s disease (HD) are often
evident before disease onset and extend through the brain during manifest stages. The trajectory of these brain abnormalities in
symptomatic stages remains relatively unexplored. The aim of this study is to investigate how the pattern of WM and gray matter
(GM) alterations progress over time.
METHODS: We investigated alterations in brain WM, cortical thickness, and subcortical structures using diffusion and structural
magnetic resonance imaging, in manifest HD patients (n = 13) compared to age-matched healthy controls (n = 11). Imaging and
clinical data for the HD group were collected at follow-up (7 months) to explore possible longitudinal changes.
RESULTS: Cross-sectional analyses identified significant posterior cortical thinning (P < .05) and symmetric fractional
anisotropy (FA) reduction (P < .01) in brain WM of HD group compared to HC. These changes were strongly correlated with
impairment in motor symptoms and processing speed. Subcortical atrophy was significant in caudate, putamen, globus pallidus,
and thalamus (P < .001). Regions of interest analysis revealed a significant reduction in FA of the corpus callosum (CC) (–2.19%,
P < .05) upon follow-up, whereas no significant cortical thinning and subcortical atrophy was found.
CONCLUSIONS: This study showed broad GM and WM abnormalities in manifest HD patients. Reductions in FA and cortical
thinning correlated significantly with the disturbances of motor and cognitive processing that describe HD. Follow-up assessment
showed that the CC is compromised in the absence of detectable GM changes or motor decline, suggesting it plays an important
role in disease progression.
Keywords: Huntington’s disease, white matter, cortical thinning, clinical markers.
Acceptance: Received November 6, 2019, and in revised form February 6, 2020. Accepted for publication February 18, 2020.
Correspondence: Address correspondence to Wafaa Sweidan, University Health Center, Detroit, MI. E-mail: et2975@wayne.edu




Huntington’s disease (HD) is an autosomal dominant and pro-
gressive neurodegenerative disorder caused by an expansion of
the CAG (glutamine) triplet in exon-1 of the huntingtin gene
(HTT).1 The hallmark of HD neuropathology is the massive loss
of medium spiny neurons in the striatum2 and with disease pro-
gression there is involvement of the cerebral cortex and other
subcortical structures.3 Clinically, HD is characterized by motor
abnormalities, variable mood disturbances,6 such as depression,
apathy, and irritability, as well as cognitive deterioration4,5 cul-
minating in dementia. As symptomology extends beyond the
motor dysfunction to involve mood and cognition, prominent
cortical and subcortical pathological changes are known to con-
tribute to the clinical status in HD. Morphological magnetic res-
onance imaging (MRI) studies have demonstrated cortical thin-
ning in primary cerebral areas (sensory, motor, and visual) and
higher cortical regions with disease progression, with a relative
conservation of the most anterior frontal and inferior tempo-
ral regions.3,4 However, little is known about the effects of HD
on white matter (WM) regions as the disease progresses. The
TRACK-ON HD study, a longitudinal study of 72 HD patients
over 24 months, demonstrated a hierarchy of WM vulnerability
in premanifest HD, where cortico-striatal connections are most
affected, followed by interhemispheric and intrahemispheric
connections.6
Given that changes in structure may manifest as changes
in local diffusion of water, diffusion tensor imaging (DTI) can
be used to infer WM microstructural changes related to HD
pathology. DTI measures the overall orientation of WM bun-
dles, with a principal outcome measure of fractional anisotropy
(FA), which describes the directionality of diffusion and is re-
lated to the presence and coherence of orientated structures.7
Mean diffusivity (MD) is another DTI parameter that character-
izes the overall diffusion and is related to the overall presence of
obstacles to diffusion. In this regard, few longitudinal studies are
available to characterize the trajectory of gray matter (GM) and
WM abnormalities over time and its relation with the clinical
status of the patient. The IMAGE-HD study provided the first
evidence for a longitudinal reduction in FA in the corpus callo-
sum (CC) and cingulum of the symptomatic HD group over a
period of 18 months.8 An important question is whether these
pathological changes are also detectable at shorter follow-up
periods.
In this study, we aim to investigate brain changes associated
with HD progression by analyzing microstructural changes in
WM regions, cortical thickness, and subcortical atrophy over a
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period of 7 months, in an attempt to identify key biomarkers
for disease progression. This will allow us to identify short-term
brain changes in the absence of significant clinical deteriora-
tion. For this purpose, initially we performed tract-based spatial
statistics (TBSS) to investigate abnormalities in WM and study
its correlation with CAG-repeats length and clinical measures
of motor severity and cognition dysfunction. Second, we aimed
to investigate the longitudinal changes in FA and MD upon
follow-up. In addition, we studied the longitudinal changes of
the well-documented cortical abnormalities in manifest HD pa-
tients. We predicted that upon follow-up, cortical thinning will
extend to more areas compared to baseline, preceding the cog-
nitive deterioration that would be expected. We also expected
that FA will be significantly lower upon follow-up.
Methods
All aspects of this study, including subject recruitment and con-
sent process, were approved by the Institutional Review Board
at Wayne State University and Detroit Medical Center.
Participants
Thirteen genetically tested HD individuals (CAG repeats  40)
were recruited from the Wayne State University/Detroit Med-
ical Center Movement Disorder Clinic. Eleven age-matched
healthy controls (HC) without a family history of neurologic dis-
eases were also enrolled from the pool of family members and
care givers who visited the clinic. All HD participants under-
went brain MRI, neuropsychological assessment, and Unified
Huntington’s Disease Rating Scale9 scoring by a movement dis-
order neurologist (EG). All HD participants were diagnosed as
symptomatic based on neurologic evaluation and UHDRS mo-
tor score >5.10 Global cognition was evaluated using the Mon-
treal Cognitive Assessment (MoCA)11; information processing
speed and working memory were evaluated using Symbol Digit
Modalities Test–oral version (SDMT). Raw SDMT scores were
converted to z-scores based on published age and gender-based
normative data.12 Impaired SDMT performance was defined
as z-score –1.5. HD participants returned for their follow-up
scan 7 months later.
All imaging sequences were acquired on a 3-Tesla Ve-
rio Siemens scanner with a 32-channel head coil and in-
cluded: T1-weighted MPRAGE sequence (176 slices; slice
thickness of 1.3 mm; .7 mm × .7 mm in-plane resolu-
tion; Repetition time (TR)/Echo Time (TE)/Inversion time
(TI) = 1,680/3.52/900 ms; flip angle = 9o) and diffusion-
weighted (DW) axial pulsed-gradient spin-echo EPI (TR/TE =
10,400/126 ms; flip angle = 90˚; 46 contiguous slices; 1.28 mm
× 1.28 mm × 3 mm; acquisition matrix 128 × 128 with
b-value = 1,000 s/mm2 [20 scans] and b-value = 0 s/mm2 [two
scans]). T2 FLAIR images (1 mm × 1 mm × 3 mm; flip angle =
150o; TR/TE/TI = 9,000/128/2500 ms) were acquired to assess
any pathological lesions, including microvascular angiopathy,
prior stroke, or other lesions.
MRI Preprocessing
DW Images were preprocessed using the FSL software (Version
5.0.4; http://www.fmrib.ox.ac.uk/fsl/). All DTI images were
corrected for eddy current-induced distortions and head mo-
tion using the FSL tool eddy correct and the gradient direc-
tions (bvecs) were rotated accordingly using fdt rotate bvecs
(Leemans and Jones, 2009). Diffusion data of 1 HD subject at
baseline and 1 HD subject at follow-up showed severe motion
artefacts and were excluded from analysis.
Maps of FA and MD were created by fitting the diffusion
tensor images with weighted least-squares using “dtifit” tool
from the FSL toolbox to create.
TBSS Analysis
TBSS was performed using FSL as described previously.13 In
the baseline analysis, FA maps of the HD and HC participants
were used to generate a group-wise skeleton of WM tracts,
thresholding the FA skeleton at .2 and resulting in a mask
of 128,432 pixels. Between-group (HD vs. HC) t-tests were
performed using the function “Randomise” from FSL14 on
the skeletonized WM fiber tracts for FA and MD maps.
The number of Randomise permutations was 10,000 with
threshold-free cluster enhancement (TFCE) and corrected for
multiple comparisons using family wise error correction.
To explore the trend of FA changes in time, a subject-specific
template was created to enhance individual subject image align-
ment across time points.15 Baseline FA map was registered to
follow-up FA map and vice versa (follow-up to baseline). The
halfway point between the two registered images was com-
puted. Then, a halfway registration was performed between
the baseline FA and follow-up FA map for each subject. Next,
a subject-specific template was created by averaging the two
halfway registered FA images. The subject-specific template was
transformed to MNI (Montreal Neurological Institute) space.
The resulting transform was then applied to the baseline and
follow-up FA maps in halfway space. After registration of the
halfway images to MNI space, TBSS processing routines was
continued as above.
Between time points (baseline and follow-up) comparisons of
HD group were then analyzed using paired t-test (TBSS, TFCE
enabled, 5,000 permutation) for FA and MD measures, which
enabled us to investigate the longitudinal changes in diffusion
metrics in the HD group.
Finally, we investigated voxelwise correlations of FA with
clinical variables in the HD group using TBSS. All resulting
statistical maps were thresholded at a family-wise error cor-
rected P-value (pFWE) <.05. For clusters showing significant
correlation of FA with clinical variables, we extracted mean
FA values of all HD subjects from the tracts of interest and
plotted them against UHDRS and SDMT scores to test their
relationship using Pearson’s correlation analysis. All the gen-
eral linear model (GLM) designs included demeaned age and
sex as nuisance covariates. All the results were anatomically lo-
calized using the JHU ICBM-DTI-81 White-Matter Labels and
the JHU White-Matter Tractography atlases.
FreeSurfer Analysis Pipeline
FreeSurfer (version 5.3.0; http://surfer.nmr.mgh.harvard.edu)
was used to derive measures of cortical thickness and deep GM
nuclei volume. The automated procedures for cortical recon-
struction and volumetric segmentation have been previously
described.16 Subcortical GM nuclei volumes included in the
analysis were as follows: caudate, putamen, globus pallidum,
and thalamus. For each hemisphere, a GLM was computed
vertex-by-vertex for analysis of cortical thickness, accounting
for the effects of gender and age.
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The design matrix was created using DODS (different
offsets, different slopes) that assumes different offsets but a
different impact of duration between groups (different slope),
which might be plausible in this study. Cortical maps were
smoothed using a 10-mm full width at half maximum Gaus-
sian kernel and the results were visualized by overlaying sig-
nificant cortical areas onto semi-inflated cortical surfaces. Mul-
tiple comparisons were corrected with a false discovery rate
(FDR) < .05.
The association between cortical morphometric measures
and clinical measures in each clinical group was also examined
using Query, Design, Estimate, Contrast application (QDEC)
in FreeSurfer. CAG repeats, measures of motor severity as mea-
sured by UHDRS-III, global cognitive function, and processing
speed as measured by the MOCA and SDMT were included in
the analyses individually as continuous covariates (FDR < .05).
Finally, FreeSurfer’s paired analysis pipeline was used to inves-
tigate cortical thickness changes in HD group at baseline versus
follow-up.
Statistics
Demographic and cognitive data were analyzed in R-Studio
(RStudio Team, 2016, version 3.4.4), and included χ2 for cate-
gorical and Wilcoxon ranks sum test for continuous variables.
Assumptions for normality were tested using the Shapiro-Wilk
normality test.
Average subcortical volumes between right and left
hemispheres, were compared between groups first using
MANCOVA, with age, sex, and intracranial volume (ICV)
as covariates. After obtaining significant group differences,
univariate differences were then analyzed using a GLM with
age, gender, and ICV as covariates.
Linear mixed effects models were used to investigate the
trajectory subcortical volume with time in the HD group. For
each subcortical volume (average of right and left hemispheres),
we modeled their interaction with time treated as “fixed effect,”
while statistically controlling for gender, age at baseline, and
the effects of randomly selected participants (“random effects”).
P-value of .05 was used as threshold for significance in all of
statistical analyses.
Results
Demographics and Group Characteristics
Table 1 summarizes the demographic and disease characteris-
tics of the HD and control groups. Age and sex did not differ
significantly between groups. Due to a small sample size, there
was a slight mismatch in the distribution of genders between
the control group and the HD group. At follow-up, only 11
HD patients underwent brain MRI on the same scanner, cogni-
tive assessment, and UHDRS scoring by the same neurologist
(EG), 1 patient was not able to do the MRI, and 1 withdrew
from the study. Global cognition as assessed by MoCA was less
than 26 in 77% of the patients, indicating an overall cognitive
impairment.
Performance on individual subscores of the MoCA was an-
alyzed, with impairment defined as less than 60% of the max-
imum score (Table 2). The most impaired items in the MoCA
were the language (1.2 ± 1.2; 41%) and delayed recall (2.8 ± 1.6;
57%). This indicates that the language and delayed recall sub-
sets contributed the most to poor scores on the MoCA.
Table 1. Demographic Data of Huntington Patients and Healthy
Controls




Age, mean ± SD 57.69 ± 12.39 57 ± 15 .5 (Wilcoxon
rank)










7.1 ± 1.0 months N/A –
UHDRS N/A .268 (paired







MoCA NA .943 (paired







SDMT z-score N/A .05089







SD = standard deviation; F = Female; M = Male; CAG = cytosine-adenine-
guanine; N/A = not applicable; n = number of subjects.
Table 2. Performance on Individual Subtests of MoCA in Huntington
Group











(Max score) n = 12 HD
Visuoexecutive (5) 3 ± 1.8 60 –2.63% .8
Naming (3) 2.6 ± .7 87 0% 1
Attention (6) 3.8 ± 1.53 63 0% 1
Language (3) 1.2 ± 1.2 41* 6.25% .75
Abstraction (2) 1.3 ± .8 65 12.5% .5
Delayed recall (5) 2.8 ± 1.6 57* 9.09% .66
Orientation (6) 5.5 ± 1.1 91 –4.54% .34
SD = standard deviation; n = number of subjects.
*Less than 60% of the maximum score.
A more specific cognitive domain, processing speed as as-
sessed by SDMT, revealed more severe cognitive deteriora-
tion, where average z-score in HD group was –3.0 ± 2.0. Upon
follow-up, there were no significant changes in UHDRS and
MoCA scores in HD group. However, SDMT scores decreased
significantly, from –3.0 at baseline to –3.2 SD below the mean
(P = .05) at follow-up.
HD-Related Effects on WM
TBSS analysis showed symmetrical lower FA and higher MD in
HD group compared to HC (see Fig 1). Area of significant WM
FA reduction included the cingulum, genu, body, and splenium
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Fig 1. White matter abnormalities in Huntington disease patients compared to healthy controls. The FA skeleton is represented in green (panels
A and B), and significant reductions in FA values shown in yellow-red (panel A). Mean diffusivity results (panel B) show areas of significantly
higher mean diffusivity in HD group (light blue-dark blue colors) overlaid with FA skeleton (green). Threshold-free cluster enhancement P < .01.
Group differences are overlaid on the FA template (FMRIB58 1 mm).
of CC, external capsule, anterior and posterior limb of internal
capsule, posterior thalamic radiation, superior corona radiata,
and superior longitudinal fasciculus (10,000 permutations,
TFCE corrected, P < .01). Similarly, areas of higher MD in
HD group compared with HC were widespread and included,
beside areas of lower FA, the anterior corona radiate and fornix.
Voxelwise correlations between DTI parameters and clin-
ical variables in HD group revealed several regions with cor-
relations to specific clinical variables. FA was negatively corre-
lated with UHDRS score (severity of motor symptoms) in genu,
body, and splenium of CC and in posterior thalamic radiation
(Fig 2A). In addition, FA was positively correlated with SDMT
z-score in more posterior regions (Fig 2B). Lower SDMT scores
correlated with FA in the posterior corona radiata, superior
longitudinal fasciculus, posterior thalamic radiation, body and
splenium of CC, sagittal stratum, and the retrolenticular part
of internal capsule. Furthermore, we extracted FA values from
some of the WM areas that showed correlation with clinical
measures, such as the CC subregions, thalamic radiation, and
internal capsule. We found a significant negative correlation be-
tween FA and UHDRS in the genu and thalamic radiation, and
a positive correlation between FA and SDMT z-scores in the
internal capsule and thalamic radiation as well (Fig 3). There
were no clusters of significant correlation between FA values
and MoCA score or number of CAG repeats.
Longitudinal TBSS analysis of FA and MD in the HD group
revealed no significant diffusivity changes for the follow-up pe-
riod of 7 months. Region of interest analysis of the three CC
sub-regions—anterior, body, and posterior—revealed significant
decreased in FA upon follow-up in the HD group in the ante-
rior (baseline: .435 ± .021 vs. follow-up: .426 ± .022, P = .0274)
and posterior (baseline: .575 ± .028 vs. follow-up: .562 ± .030,
P = .0421) CC, where the average percentage FA change in
both regions was 2.19 ± .13% (Fig 4). The reduction in FA did
not correlate with the decreased performance on the SDMT
task, which might indicate another mechanism mediating this
decline.
Cortical Thinning and Subcortical Atrophy in HD
Group comparisons of cortical parcellation maps showed sig-
nificantly lower cortical thickness in the primary the precentral
(primary motor) and left postcentral (primary sensory) gyri.
Moreover, significant cortical thinning was present in associa-
tion cortical areas: the right lingual and fusiform gyri, and left
supramarginal area in HD compared to HC (Fig 5). In addition,
cortical thinning extended to right superior temporal and right
and left inferior parietal lobules.
Cortical thinning in the HD group correlated negatively
with higher motor scores on the UHDRS in the postcentral
gyrus, superior frontal lobe, superior and middle temporal lobe,
inferior parietal lobe, pars opercularis and pars triangularis, and
lingual and lateral orbitofrontal gyrus, whereas lower MoCA
scores correlated positively with cortical thinning in the lingual
and fusiform gyri, supramarginal gyrus, and lateral orbitofrontal
lobe. Similarly, lower z-scores on SDMT were associated with
cortical thinning in the medial orbitofrontal lobe, middle
and inferior temporal lobe, lingual and supramarginal gyri,
superior frontal, superior parietal, and lateral occipital lobes
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Fig 2. Results of correlation in HD patients between FA and UHDRS. (A) Blue voxels show white matter clusters where the FA is negatively
correlated with UHDRS score and FA in genu and splenium of corpus callosum (CC) and optic radiation. (B) White matter clusters showing a
significant positive correlation (represented in red) between SDMT score and FA in posterior corona radiation, superior longitudinal fasciculus,
inferior longitudinal fasciculus, internal capsule, and optic radiation. Results are overlaid on the mean FA skeleton (green). P < .05 corrected
for multiple comparisons using threshold-free cluster enhancement.
(Fig 6). Paired analysis in FreeSurfer revealed no significant
increase in cortical thinning for the follow-up period in the HD
group.
MANCOVA analysis between the HD and HC group with
the right and left average volume of caudate, putamen, globus
pallidus and thalamus, as dependent variables, showed a signifi-
cant overall group effect (Wilks Type III F = .15355, P = 9.924
× 10–7). GLM analysis controlling for age, sex, and ICV demon-
strated significant group differences in caudate (mean ± SEM,
3.2 ± .1 mL in HC vs. 2.1 ± .2 mL; P = 2.548 × 10–5), putamen
(5.0 ± .3 mL in HC vs. 2.7 ± .2 mL; P = 5 × 10–7), pallidum
(1.5 ± .05 mL in HC vs. .9 ± .05 mL in HD; P = 1.508 × 10–7),
and thalamus (6.7 ± .3 mL in HC vs. 6.1 ± .3 mL in HD; P =
3.180 × 10–3), corrected for multiple comparisons. Follow-up
analysis did not reveal any significant changes in subcortical
volume at follow-up versus baseline.
Discussion
The present study sought to identify short-term variations in
major WM areas, as well as cortical and subcortical atrophy in
HD subjects compared to HC, and to what degree these brain
changes are associated with severity of the motor and cognitive
dysfunction. A number of findings emerged from the results:
(1) FA in HD group was correlated with motor and cognitive
impairments and continued to decrease upon follow-up in the
CC; (2) HD subjects showed significant cortical thinning at
baseline compared to HC participants, which did not change
upon follow-up; (3) processing speed was significantly worse
upon follow-up in HD group.
Findings from previous studies have suggested that HD
has complex effects on WM microstructure. The earliest WM
changes are seen in the premanifest stage around the stria-
tum, in the CC, and in posterior WM tracts,17-18 manifested
as reduced FA and increased MD, and this insult to deep
WM extends to further tracts as the disease progresses into
the manifest stages. Although decreases in FA may arise due
to multiple pathological changes including de-myelination or
axonal damage, the exact biological process underlying these
changes remains under investigation. Recent evidence suggests
that myelin breakdown contributes to WM impairments in
pathways of the basal ganglia and motor systems, evident by
reductions in the macromolecular proton fraction from quan-
titative magnetization transfer imaging.19 Our current findings
on microstructural WM alterations are in line with previous
work.
We observed symmetrically reduced FA combined with
higher MD in WM of manifest HD subjects covering essen-
tially the whole brain. TBSS showed symmetrically lower FA
in the WM of commissural fibers (genu, body, and splenium
of CC), projection fibers (external capsule, thalamic radiation,
and corona radiata), association fibers (superior longitudinal
fasciculus), and cingulum and sagittal stratum.
Damage to the CC can interfere with its role in relaying
sensory, motor, and cognitive information between cortical
regions. In the HD group, we found a significant negative
correlation between FA and the motor severity score in the
genu and splenium of the CC. In addition, FA in the splenium,
superior longitudinal fasciculus (SLF), optic radiation, and
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Fig 3. Correlation scatterplot showing relationship between FA and baseline clinical status. UHDRS score correlated negatively with FA in
genu (A) of corpus callosum and posterior thalamic radiation (B). SDMT score correlated positively with FA left retrolenticular internal capsule
(C) and posterior thalamic radiation (D). The r-values represent Pearson’s correlation coefficient.
Fig 4. Longitudinal decrease in FA of corpus callosum (CC) in HD group. Regional longitudinal analysis revealed significant decrease in FA
in the anterior and posterior portions of the CC after 7 ± 1.0 months from baseline scan. Data are represented as mean ± SEM. *P < .05 for
comparison of FA at baseline versus follow-up.
internal capsule correlated positively with performance on the
SDMT, a measure of processing speed (Fig 2). The involve-
ment of the splenium and optic radiation could be explained
by the need to transfer information between hemispheres
during the task and the visuospatial demands.20 The SLF is
also a prominent contributor to processing speed through
frontoparietal integration.21 These selective WM changes
highlight the degenerative effects of HD pathology on specific
WM pathways, which contributes to motor impairment and
reduced processing speed.
For the regional longitudinal analysis, we chose to focus
on the CC and cingulum. This was based on findings from
the IMAGE-HD study that showed a reduction in FA over
18 months in both the CC and middle cingulum WM, in symp-
tomatic HD subjects compared to HC.8 Thus, we hypothesized
that our HD cohort will also show a reduction in FA in the CC
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Fig 5. Vertex-wise comparisons of cortical thickness between controls and HD patients. Cortical thinning in HD patients was apparent (yellow-
red). The color scale bar shows the logarithmic scale of P values (−log10). All results were adjusted for multiple comparisons (FDR P < .05)
and corrected for age and sex.
Fig 6. Associations between cortical thinning and motor and cognitive deficits in patients with HD. Significant vertex-wise correlation between
cortical thinning and (A) UHDRS-III motor scores; (B) MoCA (C) and SDMT scores. The color scale bar shows the logarithmic scale of P values
(−log10). All results were adjusted for multiple comparisons (FDR P < .05) and corrected for age and sex.
and middle cingulum matter. Our region of interest analysis for
the three CC sub regions and the cingulum revealed significant
reduction of FA in the anterior and posterior regions of the CC.
These results suggest that microstructural abnormalities in this
WM region continue during disease manifestation stages, de-
spite negative results in whole brain longitudinal TBSS analysis.
The small sample size can explain why we were not able to de-
tect FA changes at the whole brain level. Hence, increasing our
sample size in the future will be necessary to better characterize
longitudinal changes in WM over time.
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The distribution of GM atrophy in our HD subjects involved
the primary motor and sensory areas and parietal and occipital
regions, in line with prior reports showing the earliest cortical
atrophy in posterior cortical regions, which later extends to in-
volve midline and frontal regions in manifest stage.22 Cortical
thinning potentially contributes to the disruption of both motor
and cognitive processing that characterize HD. Indeed, a strong
positive association was found between performance on the pro-
cessing speed task and atrophy in the lingual, fusiform, cuneus,
lateral occipital, and inferior parietal lobes. Similarly, a strong
negative association between UHDRS-motor score and cortical
thinning was recorded in more regions including both posterior
and anterior areas. The absence of a longitudinal change in cor-
tical atrophy might be due to the short follow-up duration that
is not enough for pathological processes to cause a measurable
effect. MRI techniques sensitive to more subtle microstructural
changes at the level of the neuronal processes can provide ear-
lier markers preceding neuronal loss.23
Despite our small sample size (n = 13) at baseline and at
follow-up (n = 12), we were able to observe changes in the an-
terior and posterior CC in as early as 7 months. It is likely that
the CC plays an important role as the disease progresses during
the manifest stages and calls for further examination of this re-
gion as a biomarker against which potential therapeutic agents
can be evaluated. Movement during MRI acquisition was ex-
cessive in 2 patients, which led us to exclude them. Cognitive
data were also not collected for the HC and no follow-up scan-
ning was done, which prevented us from comparing the rate of
GM and WM changes between groups. A larger sample size is
required to establish the usefulness of short-term follow-up to
assess changes in gray and WM areas as part of the neurode-
generative process in HD, but the data from this small sample
suggest it will be practical to use these changes as a measure of
disease progression.
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